At 68 weeks, CagriSema produced a mean body weight reduction of 22.7% from baseline
If the gain continues, your clinician may suggest restarting at the lowest dose or switching to another weight-loss medication if Mounjaro stopped working before
Unapproved products marketed online as tirzepatide tablets may pose quality, labeling, and dosing risks
Tirzepatide was designed for type 2 diabetes, where insulin resistance rather than autoimmune beta cell destruction is the primary problem
The outcomes were as follows: In STEP 5, once-weekly treatment with semaglutide 2.4 mg as an adjunct to behavioral intervention in adults with overweight (with at least one weight-related comorbidity) or obesity led to a substantial initial reduction in weight, which plateaued after approximately week 60 and was maintained for the remainder of the study. Effectiveness in Different Patient Groups While there are too many patient groups to identify and compare, we can allude to certain attributes that might improve or decrease your chances of successful weight loss: More muscle mass will always make your weight loss journey a lot easier due to the increase in basal metabolic rate Following a Healthy Diet: Following a healthy diet that is focused on blood sugar regulation, weight control, and healthy food choices will always improve your weight loss endeavors Regular exercise: This is a no-brainer
